MicroRNAs As Novel Biomarkers and Potential Therapeutic Options for Inflammatory Cardiomyopathy
Open accessAbstract
Aims: Inflammation of the heart is a complex biological and pathophysiological response of the immune system to a variety of injuries leading to tissue damage and heart failure. MicroRNAs (miRNAs) emerge as pivotal players in the development of numerous diseases, suggesting their potential utility as biomarkers for inflammation and as viable candidates for therapeutic interventions. The primary aim of this investigation was to pinpoint and assess particular miRNAs in individuals afflicted by virus-negative inflammatory dilated cardiomyopathy (DCMi). Methods and results: The study involved the analysis of 152 serum samples sourced from patients diagnosed with unexplained heart failure through endomyocardial biopsy. Among these samples, 38 belonged to DCMi patients, 24 to DCM patients, 44 to patients displaying inflammation alongside diverse viral infections, and 46 to patients solely affected by viral infections without concurrent inflammation. Additionally, serum samples from 10 healthy donors were included. The expression levels of 754 distinct miRNAs were evaluated using TaqMan OpenArray. MiR-1, miR-23, miR-142-5p, miR-155, miR-193, and miR-195 exhibited exclusive down-regulation solely in DCMi patients (P < 0.005). These miRNAs enabled effective differentiation between individuals with inflammation unlinked to viruses (DCMi) and all other participant groups (P < 0.005), boasting a specificity surpassing 86%. Conclusions: The identification of specific miRNAs offers a novel diagnostic perspective for recognizing intramyocardial inflammation within virus-negative DCMi patients. Furthermore, these miRNAs hold promise as potential candidates for tailored therapeutic strategies in the context of virus-negative DCMi.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Specific downregulation of miR-23 is observed in serum samples from patients with virus negative inflammatory dilated cardiomyopathy (152 patients with heart failure clinically).
“Specific downregulation of miR-23 is observed in serum samples from patients with virus negative inflammatory dilated cardiomyopathy (152 patients with heart failure clinically) [34].”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Shomali, N., Maashi, M. S., Baradaran, B., Sorkhabi, A. D., Sarkesh, A., Mohammadi, H., Hemmatzadeh, M., Marofi, F., Shotorbani, S. S., & Jarahian, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839945 · Cited by 24 · see citing works
RetractedInflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J. S., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2017) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,280 · see citing works
(2008) · doi:10.1038/nrg2290 · Cited by 5,199 · see citing works
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479 · see citing works
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217 · see citing works
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Catalanotto, C., Cogoni, C., & Zardo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101712 · Cited by 1,191 · see citing works
Transcriptional control of the inflammatory response
Medzhitov, R., & Horng, T. (2009) · Nature Reviews Immunology · doi:10.1038/nri2634 · Cited by 1,035 · see citing works
Emerging concepts of miRNA therapeutics: from cells to clinic
Diener, C., Keller, A., & Meese, E. U. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.02.006 · Cited by 981 · see citing works
microRNA Regulation of Inflammatory Responses
O’Connell, R. M., Rao, D. S., & Baltimore, D. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075013 · Cited by 957 · see citing works
Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007405 · Cited by 811 · see citing works
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720 · see citing works
Self-citationKühl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, C. –., Laßner, D., Poller, W. C., Kandolf, R., & Schultheiß, H. (2005) · Circulation · doi:10.1161/01.cir.0000155616.07901.35 · Cited by 710 · see citing works
Self-citationChronic Heart Failure and Inflammation
Dick, S. A., & Epelman, S. (2016) · Circulation Research · doi:10.1161/circresaha.116.308030 · Cited by 691 · see citing works
miR-155 gene: A typical multifunctional microRNA
Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.013 · Cited by 672 · see citing works
Frustaci, A., Russo, M. A., & Chimenti, C. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp249 · Cited by 604 · see citing works
Täubel, J., Hauke, W., Rump, S., Viereck, J., Bátkai, S., Poetzsch, J., Rode, L., Weigt, H., Genschel, C., Lorch, U., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa898 · Cited by 397 · see citing works
MicroRNA-155: A Master Regulator of Inflammation
Mahesh, G., & Biswas, R. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0155 · Cited by 377 · see citing works
Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment
Tahamtan, A., Teymoori‐Rad, M., Nakstad, B., & Salimi, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01377 · Cited by 355 · see citing works
Inflammation and the Blood Microvascular SystemPreprint
Pober, J. S., & Sessa, W. C. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016345 · Cited by 304 · see citing works
Circular RNAs: A Novel Class of Functional RNA Molecules with a Therapeutic Perspective
Santer, L., Bär, C., & Thum, T. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.07.001 · Cited by 277 · see citing works
miRNA Targeting: Growing beyond the Seed
Chipman, L. B., & Pasquinelli, A. E. (2019) · Trends in Genetics · doi:10.1016/j.tig.2018.12.005 · Cited by 248 · see citing works
MicroRNAs in Immune Response and Macrophage Polarization
Liu, G., & Abraham, E. H. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300068 · Cited by 243 · see citing works
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease
Denk, J., Boelmans, K., Siegismund, C., Lassner, D., Arlt, S., & Jahn, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126423 · Cited by 236 · see citing works
MicroRNAs in inflammation and immune responses
Contreras, J., & Rao, D. S. (2011) · Leukemia · doi:10.1038/leu.2011.356 · Cited by 236 · see citing works
MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis
Alivernini, S., Gremese, E., McSharry, C. P., Tolusso, B., Ferraccioli, G., McInnes, I. B., & Kurowska‐Stolarska, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01932 · Cited by 226 · see citing works
The Risks of miRNA Therapeutics: In a Drug Target Perspective
Zhang, S., Cheng, Z., Wang, Y., & Han, T. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s288859 · Cited by 216 · see citing works
Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease
Huang, C.-K., Kafert-Kasting, S., & Thum, T. (2020) · Circulation Research · doi:10.1161/circresaha.119.315856 · Cited by 213 · see citing works
MicroRNA Therapeutics in Cancer: Current Advances and Challenges
Sayed, S. R. E., Cristante, J., Guyon, L., Denis, J., Chabre, O., & Cherradi, N. (2021) · Cancers · doi:10.3390/cancers13112680 · Cited by 211 · see citing works
Preclinical development of a miR-132 inhibitor for heart failure treatment
Foinquinos, A., Bátkai, S., Genschel, C., Viereck, J., Rump, S., Gyöngyösi, M., Traxler, D., Riesenhuber, M., Spannbauer, A., Lukovic, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14349-2 · Cited by 210 · see citing works
MicroRNAs of the immune system
Davidson-Moncada, J. K., Papavasiliou, F. N., & Tam, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05121.x · Cited by 171 · see citing works
MicroRNAs: Small RNAs With Big Effects
Anglicheau, D., Muthukumar, T., & Suthanthiran, M. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e913c2 · Cited by 165 · see citing works
Li, X., Kong, D., Chen, H., Liu, S., Hu, H., Wu, T., Wang, J., Chen, W., Ning, Y., Li, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep21789 · Cited by 161 · see citing works
Schultheiß, H., Piper, C., Sowade, O., Waagstein, F., Kapp, J. F., Wegscheider, K., Groetzbach, G., Pauschinger, M., Escher, F., Arbustini, E., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-0986-9 · Cited by 143 · see citing works
Self-citationmiRNA delivery for skin wound healing
Zhao, M., Zhou, D., Gao, Y., Zeng, M., & Wang, W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.011 · Cited by 140 · see citing works
Talebi, F., Ghorbani, S., Chan, W. F., Boghozian, R., Masoumi, F., Ghasemi, S., Vojgani, M., Power, C., & Noorbakhsh, F. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0832-7 · Cited by 130 · see citing works
Verdonschot, J. A. J., Merlo, M., Domínguez, F., Wang, P., Henkens, M. T. H. M., Adriaens, M. E., Hazebroek, M. R., Masè, M., Escobar-López, L., Paz, R. C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa841 · Cited by 124 · see citing works
The spectrum of myocarditis: from pathology to the clinics
Leone, O., Pieroni, M., Rapezzi, C., & Olivotto, I. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02615-8 · Cited by 115 · see citing works
Merken, J. J., Hazebroek, M. R., van Paassen, P., Verdonschot, J. A. J., van Empel, V. P. M., Knackstedt, C., Hamid, M. A. A., Seiler, M., Kolb, J., Hoermann, P., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004228 · Cited by 104 · see citing works
MicroRNA-195: a review of its role in cancers
Yu, W., Liang, X. M., Li, X., Zhang, Y., Sun, Z., Liu, Y., & Wang, J. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s183600 · Cited by 97 · see citing works
miR‐193: A new weapon against cancer
Khordadmehr, M., Shahbazi, R., Sadreddini, S., & Baradaran, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28368 · Cited by 92 · see citing works
miR-1: A comprehensive review of its role in normal development and diverse disorders
Safa, A., Bahroudi, Z., Shoorei, H., Majidpoor, J., Abak, A., Taheri, M. N., & Ghafouri‐Fard, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110903 · Cited by 73 · see citing works
MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention
Holjencin, C. E., & Jakymiw, A. (2022) · Cells · doi:10.3390/cells11152332 · Cited by 71 · see citing works
miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
Kmiołek, T., & Paradowska‐Gorycka, A. (2022) · Cells · doi:10.3390/cells11030452 · Cited by 62 · see citing works
Kühl, U., Laßner, D., Dörner, A., Rohde, M., Escher, F., Seeberg, B., Hertel, E., Tschöpe, C., Skurk, C., Gross, U. M., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0372-y · Cited by 58 · see citing works
Self-citationBras, J. P., Silva, A. M., Calin, G. A., Barbosa, M. A., Santos, S. G., & Almeida, M. I. (2017) · PLOS ONE · doi:10.1371/journal.pone.0188530 · Cited by 49 · see citing works
McNeill, E. M., Warinner, C. B., Alkins, S., Taylor, A., Heggeness, H., DeLuca, T. F., Fulga, T. A., Wall, D. P., Griffith, L. C., & Vactor, D. V. (2020) · Nature Communications · doi:10.1038/s41467-020-14761-8 · Cited by 47 · see citing works
miRNA as activity markers in Parvo B19 associated heart disease
Kühl, U., Rohde, M., Laßner, D., Gross, U. M., Escher, F., & Schultheiß, H. (2012) · Herz · doi:10.1007/s00059-012-3656-3 · Cited by 40 · see citing works
Self-citationYu, W., Li, D., Zhang, Y., Li, C., Zhang, C., & Wang, L. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819892264 · Cited by 40 · see citing works
Kühl, U., Laßner, D., Gast, M., Stroux, A., Rohde, M., Siegismund, C. S., Wang, X., Escher, F., Gross, M. C., Skurk, C., et al. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001475 · Cited by 31 · see citing works
Self-citationInflammation between defense and disease: impact on tissue repair and chronic sickness
Liehn, E. A., & Carbrera-Fuentes, H. A. (2015) · Discoveries · doi:10.15190/d.2015.34 · Cited by 29 · see citing works
Aleshcheva, G., Pietsch, H., Escher, F., & Schultheiss, H. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13090 · Cited by 29 · see citing works
Self-citationLiu, L., Cheng, Z., & Yang, J. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.09.004 · Cited by 28 · see citing works
Lewandowski, P., Goławski, M., Baron, M., Reichman-Warmusz, E., & Wojnicz, R. (2022) · Biomolecules · doi:10.3390/biom12101476 · Cited by 26 · see citing works
Regulatory roles of micro-RNAs in T cell autoimmunity
Esmailzadeh, S., Mansoori, B., Mohammadi, A., & Baradaran, B. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1373901 · Cited by 26 · see citing works
Li, T., Lee, P., Lee, K., Hsieh, Y., Tsai, C., Yang, Y., Huang, S., Tsai, T., Hsieh, S.-L. E., Hou, M., et al. (2016) · Scientific Reports · doi:10.1038/srep39405 · Cited by 24 · see citing works
Prevalence and Clinical Implications of COVID-19 Myocarditis
Chimenti, C., Magnocavallo, M., Ballatore, F., Bernardini, F., Alfarano, M., Rocca, D. G. D., Severino, P., Lavalle, C., Fedele, F., & Frustaci, A. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2021.11.001 · Cited by 24 · see citing works
Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment
Escher, F. (2015) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2015.47750 · Cited by 23 · see citing works
Self-citationOhta-Ogo, K., Sugano, Y., Ogata, S., Nakayama, T., Komori, T., Eguchi, K., Dohi, K., Yokokawa, T., Kanamori, H., Nishimura, S., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-21-0529 · Cited by 23 · see citing works
Kühl, U., & Hp, S. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.14010 · Cited by 22 · see citing works
Role of miR‑155 in immune regulation and its relevance in oral lichen planus (Review)
Yan, T., Ai, R., Hao, Y., Jiang, L., Dan, H., Ji, N., Zeng, X. Y., Zhou, Y. J., & Chen, Q. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7019 · Cited by 20 · see citing works
Role of endothelial microRNA 155 on capillary leakage in systemic inflammation
Etzrodt, V., Idowu, T. O., Schenk, H. J., Seeliger, B., Prasse, A., Thamm, K., Pape, T., Müller‐Deile, J., van Meurs, M., Thum, T., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03500-0 · Cited by 20 · see citing works
Wang, Q., Chen, W., Yang, X., Song, Y., Sun, X., Tao, G., Wang, H., Zhao, N., Huang, Y., Chai, E., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s362368 · Cited by 18 · see citing works
Rb, Y., Li, K., Wang, G., Gm, G., & Jx, D. (2019) · PubMed · doi:10.26355/eurrev_201905_17950 · Cited by 17 · see citing works
Izadpanah, S., Shabani, P., Aghebati‐Maleki, A., Baghbani, E., Baghbanzadeh, A., Fotouhi, A., Bakhshinejad, B., Maleki, L. A., & Baradaran, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.106 · Cited by 17 · see citing works
Role of the plasma cascade systems in ischemia/reperfusion injury of bone
Zhang, S., Wotzkow, C., Bongoni, A. K., Shaw-Boden, J., Siegrist, M., Taddeo, A., Blank, F., Hofstetter, W., & Rieben, R. (2017) · Bone · doi:10.1016/j.bone.2016.12.007 · Cited by 11 · see citing works
Flagged first, then by citations
1 of the 66 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [35]Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation Lippincott Williams & Wilkins 2005; 111: 887‐ 893. doi: 10.1161/01.CIR.0000155616.07901.35 15699250 · DOI
Cited by
Sorted by citations
Drazner, M. H., Bozkurt, B., Cooper, L. T., Aggarwal, N. R., Basso, C., Bhave, N. M., Caforio, A. L. P., Ferreira, V. M., Heidecker, B., Kontorovich, A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.080 · Cited by 278 · see citing works
Beghini, A., Sammartino, A. M., Papp, Z. L., von Haehling, S., Biegus, J., Ponikowski, P. P., Adamo, M., Falco, L., Lombardi, C., Pagnesi, M., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14857 · Cited by 229 · see citing works
Iside, C., Picone, F., Pietro, P. D., Abate, A. C., Prete, V., Damato, A., Venturini, E., Akeel, S., Petralia, S., Vecchione, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110769 · Cited by 17 · see citing works
Cardiomyopathies: The Role of Non-Coding RNAs
Carabetta, N., Siracusa, C., Leo, I., Panuccio, G., Strangio, A., Sabatino, J., Torella, D., & Rosa, S. D. (2024) · Non-Coding RNA · doi:10.3390/ncrna10060053 · Cited by 11 · see citing works
Current Review of Heart Failure-Related Risk and Prognostic Factors
Wilk, M. M., Wilk, J., Urban, S., & Gajewski, P. (2024) · Biomedicines · doi:10.3390/biomedicines12112560 · Cited by 9 · see citing works
Xu, F., & Zhang, C. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01428-3 · Cited by 6 · see citing works
The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis
Młynarska, E., Badura, K., Kurciński, S., Sinkowska, J., Jakubowska, P., Rysz, J., & Franczyk, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010933 · Cited by 6 · see citing works
Recent advances of miR-23 in human diseases and growth development
Qian, X., Jiang, Y., Yang, Y., Zhang, Y., Xu, N., Xu, B., Pei, K., Yu, Z., & Wu, W. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.12.010 · Cited by 5 · see citing works
Evin, L., Šigutová, R., Šulc, P., Kufová, E., Branny, M., Václavík, J., & Stejskal, D. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1529451 · Cited by 4 · see citing works
Lai, Y., Shang, M., Yang, H., Lv, H., Zhang, P., Guo, T., Zhang, W., Yang, A., Yu, J., Qian, J., et al. (2025) · Genomics · doi:10.1016/j.ygeno.2025.111068 · Cited by 2 · see citing works
Zhang, J., Zhan, H., Xu, H., Wang, R., Li, Z., Feng, F., Wu, H., Xu, Z., Wang, S., Guo, Y., et al. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103860 · Cited by 1 · see citing works
Ma, M.-R., Song, X., Wang, X.-K., Liu, Y., Cai, X., Zheng, R.-R., Liu, M., Ma, L., Wang, F., & Ma, L. (2025) · Gene · doi:10.1016/j.gene.2025.149866 · Cited by 1 · see citing works
Kumagai, K., Kawamura, T., Torigata, K., Harada, A., Kishimoto, Y., Miyagawa, S., & Yoshikawa, Y. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101105 · Cited by 1 · see citing works
Holst, M. A. M., Navarro, F. A. S., & León-Pedroza, J. I. (2026) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2026.101975 · Cited by 1 · see citing works
Editors’ Highlight Picks from 2023 in ESC Heart Failure
Bäck, M., von Haehling, S., Papp, Z., & Piepoli, M. F. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14727 · Cited by 1 · see citing works
MicroRNAs in dilated cardiomyopathy: from biomarkers to therapeutic targets
S, A. V. J. V., Sandra, P. S. S., Vasu, M. M., Jeemon, P., Ganapathi, S., Urulangodi, M., Mohan, N., Kumar, P. R. A., Ambatipudi, S., Vijay, J., et al. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12573-5
- Authors
- Aleshcheva, G., Baumeier, C., Harms, D., Bock, C.-T., Escher, F., & Schultheiss, H.-P.
- Affiliations
- Institut Kardiale Diagnostik und Therapie (DE)
- Robert Koch Institute (DE)
- German Centre for Cardiovascular Research (DE)
- Corresponding author
- Aleshcheva, Ganna
- Venue
- ESC Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-09-07
- Volume
- 10
- Issue
- 6
- Pages
- 3410-3418
- ISSN
- 2055-5822 (ISSN-L)
- PMC
- PMC10682862
- OpenAlex
- W4386529640
- Cited by
- 17
- References
- 66
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 1
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- ESC Heart Failure (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Publication server of the Robert Koch Institute (Robert Kock Institute) (acceptedVersion, cc-by)
- Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- EFRE (10169028)
- European Regional Development Fund (10169028)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Keywords
- microRNA, inflammatory dilated cardiomyopathy, cardiomyocyte inflammation, serum biomarkers, heart failure, miR-1, miR-23, miR-142-5p, miR-155, miR-193, miR-195, diagnostic biomarkers, therapeutic target
- MeSH terms
- Cardiomyopathy, Dilated, Heart Failure, Humans, Inflammation, Myocarditis, Virus Diseases, Biomarkers, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
